Login to Your Account


Other News To Note


Thursday, September 6, 2012
• AMAG Pharmaceuticals Inc., of Lexington, Mass., received marketing authorization in Switzerland for Reinso (ferumoxytol) for iron deficiency anemia in adults with chronic kidney disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription


»

For Sales Inquiries,
http://clarivate.com/life-sciences/news/bioworld/#

 
Privacy Policy | Terms of Use | Copyright
 
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Clarivate Analytics